Summary
Background Cutaneous T-cell lymphomas (CTCL) are rare cancers, which can be difficult to diagnose, are incurable and adversely affect quality of life, particularly in advanced disease. Families often provide care, but little is known about their experiences or needs while caring for their relative with advanced disease or in bereavement. Objectives To explore the experiences of bereaved family caregivers of patients with CTCL. Methods Single, semi-structured qualitative interviews were conducted with bereaved family caregivers of patients with CTCL recruited via a supra-regional CTCL clinic. Transcribed interviews were analysed thematically, focusing on advanced disease, the approach of death and bereavement. Results Fifteen carers of 11 deceased patients participated. Experiences clustered under four themes: (1) complexity of care and medical intervention; (2) caregiver roles in advanced CTCL; (3) person-centred vs. organization-centred care in advanced CTCL and (4) knowing and not knowing: reflections on dying, death and bereavement. Caregivers often had vivid recollections of the challenges of caring for their relative with advanced CTCL and some took on quasi-professional roles as a result. Advanced disease made high demands on both organizational flexibility and family resources. For many caregivers, seeing disease progression was a prolonged and profoundly traumatic experience. The extent to which they were prepared for their relative's death and supported in bereavement was highly variable. Sub-themes within each theme provide more detail about caregiver experiences. Conclusions Family caregivers should be considered part of the wider healthcare team, acknowledging their multiple roles and the challenges they encounter in looking after their relative with CTCL as the disease progresses. Their experiences highlight the importance of organizational flexibility and of good communication between healthcare providers in advanced CTCL.
What's already known about this topic?
• Cutaneous T-cell lymphoma (CTCL) is a rare cancer with multiple negative impacts on the quality of life of patients and their carers, particularly in advanced disease.
• Care of extensive skin lesions in advanced CTCL is complex and time-consuming.
• A systematic review of the literature on CTCL revealed no exploration of the needs or experiences of family carers.
What does this study add?
• Care for patients with advanced CTCL is complex and challenging, and family caregivers can adopt quasi-professional roles.
• Even in advanced CTCL and despite multiple hospital admissions, family caregivers may not expect their relative's death and experience highly variable bereavement support.
• Healthcare providers should consider the support needs of family caregivers as well as those of patients with advanced CTCL and support should be provided during the course of the disease and into bereavement, whatever the place of care and death.
What are the clinical implications of the work?
• Healthcare providers need to take a flexible, person-centred approach to care, rather than relying on existing organizational systems to meet the needs of complex patients with the extensive skin breakdown present in advanced CTCL.
• CTCL raises specific challenges for caregivers given its initially benign appearance and rarity -adapting to the worsening symptoms and prognosis may require specific support for family caregivers.
Primary cutaneous T-cell lymphomas (CTCL) are rare nonHodgkin lymphomas affecting the skin. Of these, mycosis fungoides and S ezary syndrome are the most common. There is a reported incidence of 7Á7 per 1 000 000 person-years with a M : F ratio of 1Á72 : 1 1 3 although qualitative research with patients had identified the need for greater understanding of the challenges of living with this disease. 4 We have since reported findings from our study of family members currently caring for patients with CTCL and found that CTCL had a profound impact on family dynamics and relationships. 5 However, up to now there have been no studies of bereaved caregivers' experiences of the advanced disease of their relative, the approach of death and bereavement and, therefore, there is little evidence to inform care delivery for this group. It is possible that their experiences might differ from those of caregivers of people with other forms of advanced cancer given the challenges of widespread skin involvement. In this study we aimed to explore the experiences of bereaved caregivers of patients with CTCL leading up to and beyond the death of the patient.
Methods Design
In-depth, face-to-face, semi-structured qualitative interviews were conducted with bereaved caregivers of patients with CTCL. The study was overseen by a steering group and also a user group of two patients and a carer, meeting every 6 months, who provided useful guidance on overall study design and the development of the topic guide.
Setting
Participants were caregivers of patients who had some or all of their care at a supra-regional CTCL clinic.
Recruitment
Personally addressed letters inviting participation in the research were sent to the next of kin/person registering each patient's death by the consultant who had led the care. The addressees were identified from the patient database at the supra-regional CTCL clinic. In line with the methodology of a major bereavement survey, 6 caregivers were not approached in the first 4 months after the death. As this is a small population, caregivers of patients listed on the departmental database who had died up to 3 years earlier were approached. A reply slip was provided, and people were invited to call the lead researcher (E.R.) or the team psychologist (D.O.) if they wished. Participants were recruited through this single approach -no follow-up letters were sent after the initial invitation. Inclusion criteria were that their deceased relative had CTCL as the primary or secondary cause of death and that they could take part in an interview in English.
Data collection
Face-to-face, single, semi-structured interviews were conducted by an experienced medical sociologist (E.R.) using an interview topic guide, with the following sub-categories: demographics; history of illness; living with CTCL; the future and preferences for care. The interview is in Appendix S1. The topic guide was informed by the literature, and reviewed by the user group. Caregivers were interviewed at a time convenient to them, usually in their homes. Interviews were recorded digitally.
Analysis
Interviews were transcribed verbatim by a professional transcriber and anonymized. ID numbers were assigned to each participant. Data were analysed thematically 7 in three stages.
(i) The complete set of interview transcripts was read and reread by the lead author to become familiar with the data, with initial notes made about the content and emerging themes.
(ii) A draft coding frame was created, using an inductive approach and constant comparison to create a conceptually coherent hierarchy of themes and sub-themes specifically related to caregivers' experiences of the advanced disease of their relative, the approach of death and bereavement. (iii) The coding frame was revised through an iterative process of re-interrogating the data and discussing emerging themes with co-authors (L.E.S., R.H., T.B.). Finally, a narrative was constructed with input from all authors.
Ethical issues
Ethical approval was granted by the U.K. National Research Ethics Service (NRES reference: 11/H0713/11) and written informed consent obtained from all participants. In view of the potential for participant distress during the interviews, access to the medical team's clinical psychologist was made available (however, none made contact). The interviewer offered to stop the interview for a period if a participant became upset and this happened several times.
Results
Seventeen invitation letters were sent to potential participants. Two were returned to sender (presumably the addressee having moved). Of the remaining 15, 11 contacted the researcher wishing to participate. Four had family members who had also played a major role in caregiving for the patient and wished to participate.
Participant characteristics
Participant characteristics are displayed in Table 1 . All participants described themselves as White British and were from a range of occupational backgrounds. Seven interviews were with one carer (partner/spouse), and four were joint interviews with a bereaved spouse/partner and their adult son/daughter.
The caregivers' accounts identified that deceased patients had received a variety of treatments over time including total skin electron beam therapy, chemotherapy, extracorporeal photopheresis, bexarotene, interferon, psoralen plus ultraviolet A, nitrogen mustard and radiotherapy. Two had stem-cell transplants for CTCL.
Findings
Four main themes were identified: Sub-themes identified are referred to in the text. Table S1 contains exemplifying quotes from the interviews (potentially identifying details have been removed). Good communication affects all aspects of patient and caregiver experience from diagnosis, through treatment and to death. In this paper aspects of communication are reflected within individual themes (particularly themes 2, 3 and 4), rather than being illustrated as an individual theme.
Complexity of care and medical intervention
Four sub-themes were identified relating to the nature of advanced CTCL: (i) vivid descriptions of advanced disease; (ii) the challenges of skin care and wound dressings; (iii) the impact of advanced CTCL and comorbidities on care options; and (iv) variations in health professionals' knowledge about the disease. The challenges of skin care and wound dressings Bereaved caregivers reported that looking after the skin of the patient, applying specialist dressings and providing skilled care was a major challenge [Q6] . Some caregivers were involved in this care themselves (section 2.1). One suggested the need for specialist dressings that did not need daily changing and another was pleased that a hospice used a form of nonstick bed sheet. In extremis, there was also creative use of high-street products (sanitary towels and maternity knickers for wounds in the groin) [Q7] . When in hospital, caregivers said they had appreciated a consistent staff team who knew how to handle their relative's dressings [Q8].
The impact of advanced cutaneous T-cell lymphoma and comorbidities on care options The extensive skin involvement of advanced CTCL could stand in the way of taken-for-granted approaches to care (e.g. Variations in health professionals' knowledge about cutaneous T-cell lymphoma Caregivers spoke of local healthcare providers not having knowledge of CTCL [Q15]. While this is not surprising given the rarity of the disease, it could mean that disease progression was not spotted and symptoms mistakenly attributed to more benign causes. Examples of this were oral involvement being attributed to an ulcer rather than disease progression [Q16] and local health professionals not understanding that there had been a change in colour of a patient's skin [Q17].
Caregiver roles in advanced cutaneous T-cell lymphoma
To a greater or lesser extent, families of patients with advanced disease found themselves involved in the wider team of medical and nursing staff in a variety of settings. Four subthemes emerged describing the different roles caregivers took on: caregivers as (i) hands-on providers and care coordinators; (ii) advocates; (iii) decision-makers and (iv) contributors to medical knowledge. 
Family caregivers as hands-on providers and care coordinators

Person-centred vs. organization-centred care
The reports of some caregivers suggested that care was not always person-centred. Rather than creative solutions being found to address each patient's unique needs towards the end of life, they were sometimes expected to fit into healthcare organizations' systems and processes. Two sub-themes emerged: (i) the specific impact of time pressure on care and (ii) organizational challenges to person-centred care.
Impact of time pressure on care Some caregivers reported that shortages of time and/or staff had adverse impacts on patient care: time pressure affected how dressing changes were managed [Q31], and on occasions some lesions were left without radiotherapy treatment with painful results for the patient [Q32]. One recalled that the simple act of giving of tablets in hospital had not taken into account the time the patient needed to swallow them given his sore mouth [Q33].
Organizational challenges to person-centred care One caregiver contrasted the approach of staff working in a separate hospital department, only one of whom he believed took the pain of the patient into account when a referral was made for inpatient tests [Q34] . Another recalled her husband telling his medical team he thought he was being seen as a set of separate biological systems rather than a whole person [Q35]. There were also comments that the organization of patient transport and appointment times did not always take patient fatigue and extreme skin discomfort into consideration.
Challenges about the location of care sometimes emerged if patients outlived initial expectations. One caregiver was aware of debate in a hospice clinical team regarding where her relative could receive care as the hospice could not admit patients for extended periods [Q36] . Despite the intensity of carer involvement (see section 2), significant choices were sometimes made by others: one caregiver was distraught that despite her specific request, a paid carer coming to the home had not woken her when her husband's condition had deteriorated on the day of his death [Q37], which also illustrates poor communication on the part of the paid carer at this delicate time.
Knowing and not knowing: reflections on dying, death and bereavement
Four sub-themes relating to caregivers' experiences of their relative's death and their own subsequent bereavement were identified: (i) understanding of prognosis and approaching death; (ii) admissions and interventions at the end of life; (iii) reflections on death with CTCL and (iv) bereavement support.
Understanding of prognosis and approaching death Bereaved family caregivers varied in the extent to which they had been aware of the prognosis and likelihood of approaching death. In part this related to early consultations in which varying amounts of information had been given. Looking back, one family was surprised at the severity of CTCL and thought they would have asked more questions had they known what might happen [Q38]. In contrast, another was pleased with the communication and grateful that the severity had been clarified from the outset, as this had enabled practical matters to be addressed 
Discussion
This is the first study to explore the experiences of bereaved family caregivers of patients with CTCL. While CTCL does not progress to death for all patients, 2 the experiences reported here offer a rarely glimpsed picture of the challenges of advanced CTCL not just for the patient but for the family. The challenges encountered by caregivers were considerable and their dedication was clear. Witnessing a relative with CTCL progress from diagnosis to death was for many family caregivers a prolonged and profoundly traumatic experience. As in our study of current caregivers of patients with CTCL, 8 bereaved family caregivers reported having been overwhelmed by the demands of caregiving and the impact of CTCL on their lives. Our findings support previous work highlighting multiple problems and responsibilities faced by family caregivers of patients with cancer. 9 The sometimes distressing accounts of bereaved family caregivers suggest that this is a vulnerable group and this is consistent with previous work on bereaved spousal caregivers of patients with cancer. 10, 11 However, the extent to which caregivers were prepared for the death of their relative and supported in their bereavement was highly variable, indicating inconsistency in the services and care available. Our findings have several clinical implications. Healthcare providers need to take a flexible, person-centred approach to care, rather than relying on existing organizational systems to meet the needs of complex patients with the extensive skin breakdown that is present in advanced CTCL. As in other lifelimiting conditions, caregivers also need to be recognized as separate from but integral to the care being delivered to the patient. CTCL raises specific challenges for caregivers given its initially benign appearance and rarity -adapting to the worsening symptoms and prognosis may require specific support. Given the varied roles taken on by family caregivers of patients with advanced CTCL, practical and emotional support and information tailored to their needs and preferences should be provided during the course of the disease. This should be accessible regardless of place of care and death and should continue into bereavement.
The complexity of care for patients with advanced CTCL highlights the value of good communication, which was not always present in the experiences of participants in this study. This includes communication between healthcare providers and family caregivers (who will often have a detailed understanding of the impact of advanced disease on their relative) and among healthcare providers supporting the patient across different settings (e.g. specialist centre, local hospital, hospice) over time. The extensive care needs in advanced CTCL also serve to highlight the importance of the role of clinical nurse specialists (CNSs) in the care of this patient group and indeed in liaison between care settings. CNSs are involved in looking after patients with CTCL in various locations in the U.K., and CNS involvement is specifically recommended in melanoma and nonmelanoma skin cancers. 12, 13 We argue that CNSs are equally important in looking after patients with CTCL.
Turning to the challenging experiences of the approach of death in patients with advanced CTCL, families may have got used to a disease trajectory more typical of organ failure with long-term limitations with intermittent serious episodes than of cancer 14 and find it hard to anticipate a final decline in the health of their relative. This highlights the value of sensitive conversations about what the patient and their family would find acceptable and unacceptable in terms of quality of life and medical intervention as life ends. 15 This could spare patients futile and distressing interventions that they would not wish to undergo and could spare their families potentially distressing memories. Following the death of the patient, letters of condolence from consultants were valued by bereaved relatives and this practice should be encouraged. Our study has several limitations. It is possible that carers who participated had different (potentially worse) experiences than those who did not. Given the small population, we could not aim for a purposive sample across carer or patient characteristics. Although not all the patients were White British, our carer sample consisted of White British family members; however, our participants were diverse in terms of age and both men and women caregivers participated. We are also confident that we achieved sufficient information power to meet the exploratory aims of the study. 16 In conclusion, this study adds the bereaved family caregiver perspective to the evidence regarding the experiences of patients with CTCL and their families. Advanced disease places considerable demands on patients, their medical teams and family, regardless of care setting. Family caregivers should be considered as part of the wider care team, acknowledging their multiple roles in caring for relatives with this rare disease, the impact of witnessing advanced disease and then experiencing bereavement from CTCL.
